Vitamin A enriched rice (Golden Rice) is a cost-efficient solution that can
substantially reduce health costs. Despite Golden Rice being available since early 2000,
this rice has not been introduced in any country. Governments must perceive additional
costs that overcompensate the benefits of the technology to explain the delay in approval.
We develop a real option model including irreversibility and uncertainty about perceived
costs and arrival of new information to explain a delay in approval. The model has
been applied to the case of India. Results show the annual perceived costs have to be
at least US$199 million per year approximately for the last decade to explain the delay in
approval of the technology. This is an indicator of the economic power of the opposition
towards Golden Rice resulting in about 1.4 million life years lost over the past decade
in India.
SOURCE: CAMBRIDGE JOURNAL
No comments:
Post a Comment